Sericin inhibits MDA-MB-468 cell proliferation via the PI3K/Akt pathway in triple-negative breast cancer

Triple negative breast cancer (TNBC) is a subtype of breast cancer characterized by an aggressive histology and poor prognosis, with limited treatment options in the clinic. In the present study, the effect of sericin, as an anti-cancer drug, on TNBC cell proliferation was investigated using a MTT a...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Lin, Yang, Songhe, Zhao, Xueying, Liu, Xiaochao, Si, Lina, Wei, Meng, Liu, Lei, Cheng, Luyang, Qiao, Yuebing, Chen, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751468/
https://www.ncbi.nlm.nih.gov/pubmed/33313947
http://dx.doi.org/10.3892/mmr.2020.11779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751468/
https://www.ncbi.nlm.nih.gov/pubmed/33313947
http://dx.doi.org/10.3892/mmr.2020.11779

Ejemplares similares